Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016. (Q34646321)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016. |
scientific article |
Statements
Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016 (English)
Joseph M Unger
Lisa M Rimsza
Jonathan W Friedberg
Michael LeBlanc
Myron S Czuczman
Mark Kaminski
Rita M Braziel
Catherine Spier
Shaker R Dakhil
Thomas P Miller
Richard I Fisher
David G Maloney
10 December 2012
1 reference